Home Authors Posts by Caproasia

Caproasia

Caproasia
17655 POSTS 0 COMMENTS
Caproasia.com covering capital markets, investments and private wealth in Asia. Our users manage, advise & invest $25 trillion assets in Asia

India $46 Billion Pharmaceutical Giant Sun Pharma Buys United States Healthcare...

0
India $46 Billion Pharmaceutical Giant Sun Pharma Buys United States Healthcare Company Organon for $11.75 Billion (Include Debt) in All-Cash Deal, Organon Founded in...

Japan $710 Million Real Estate Developer Goldcrest Co Buys Tokyo Office...

0
Japan $710 Million Real Estate Developer Goldcrest Co Buys Tokyo Office Building Pasona Square for $628 Million (JPY 100 Billion) from United States $90...

United States $938 Billion Private Equity Firm Apollo Global Management Buys...

0
United States $938 Billion Private Equity Firm Apollo Global Management Buys Forvia Interiors from France $2.2 Billion Automotive Supplier Forvia $2.1 Billion (€1.82 Billion,...

United States $303 Billion Private Equity Firm TPG Buys Majority Stake...

0
United States $303 Billion Private Equity Firm TPG Buys Majority Stake of Japan Logistics Assets from Singapore $77 Billion Real Estate Firm ESR Group 2nd...

United States $1.7 Billion Mining Development Firm Critical Metals Buys Australia...

0
United States $1.7 Billion Mining Development Firm Critical Metals Buys Australia Mining Exploration Firm European Lithium for $835 Million (AUD 1.2 Billion) in All-Share...

UK $250 Billion Oil Giant Shell Buys Canada Energy Company ARC...

0
UK $250 Billion Oil Giant Shell Buys Canada Energy Company ARC Resources for $16.4 Billion (CAD 22.9 Billion) in Cash & Share Deal (25%...

United States $4.6 Billion Biopharmaceutical Royalty Aggregator Company Ligand Pharmaceuticals Buys...

0
United States $4.6 Billion Biopharmaceutical Royalty Aggregator Company Ligand Pharmaceuticals Buys United States Biotechnology Royalty Aggregator XOMA Royalty for $739 Million in All-Cash Deal...

United States $808 Billion Biopharmaceutical Giant Eli Lilly Buys United States...

0
United States $808 Billion Biopharmaceutical Giant Eli Lilly Buys United States Clinical-Stage Biopharmaceutical Company Ajax Therapeutics for $2.3 Billion in All-Cash Deal (Include Contingents),...

United States Clinical-Stage Neuropsychiatric Disorders Company Seaport Therapeutics Nasdaq IPO Share...

0
United States Clinical-Stage Neuropsychiatric Disorders Company Seaport Therapeutics Nasdaq IPO Share Price Increased +10.2% on Day 1 Trading (1/5/26: IPO Price: $18, Closing $19.84)...

United States-Denmark Clinical-Stage Bleeding Disorder Biotech Company Hemab Therapeutics Nasdaq IPO...

0
United States-Denmark Clinical-Stage Bleeding Disorder Biotech Company Hemab Therapeutics Nasdaq IPO Share Price Increased +88.9% on Day 1 Trading (1/5/26: IPO Price: $18, Closing...